Trial watch: dendritic cell vaccination for cancer immunotherapy
Sign Up to like & getrecommendations! Published in 2019 at "OncoImmunology"
DOI: 10.1080/2162402x.2019.1638212
Abstract: ABSTRACT Dendritic- cells (DCs) have received considerable attention as potential targets for the development of anticancer vaccines. DC-based anticancer vaccination relies on patient-derived DCs pulsed with a source of tumor-associated antigens (TAAs) in the context… read more here.
Keywords: cell vaccination; dendritic cell; trial watch; vaccination ... See more keywords